Oncolytics Biotech Stock (NASDAQ: ONCY) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 369.431K |
Day Range | - - - |
52 Wk Range | 0.883 - 3.394 |
Market Cap | $77.682M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 1.31% |
Days to Cover | 5.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Oncolytics Biotech (NASDAQ: ONCY) through any online brokerage.
There are no as such competitors for Oncolytics Biotech.
The latest price target for Oncolytics Biotech (NASDAQ: ONCY) was reported by Raymond James on Thursday, April 4, 2024. The analyst firm set a price target for 3.00 expecting ONCY to rise to within 12 months (a possible 191.26% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Oncolytics Biotech (NASDAQ: ONCY) is $1.03 last updated April 24, 2024 at 7:53 PM EDT.
There are no upcoming dividends for Oncolytics Biotech.
Oncolytics Biotech’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Oncolytics Biotech.
Oncolytics Biotech is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.